Find generic entry opportunities
Drug patents …
… from Kazakhstan to Kalamazoo
Manage your formulary budget
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Proactively manage your pharmacy inventory
Anticipate generic drug launch
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
|Title:||Human growth hormone DNA|
|Abstract:||Described are methods and means for the construction and microbial expression of quasi-synthetic genes arising from the combination of organic synthesis and enzymatic reverse transcription from messenger RNA sequences incomplete from the standpoint of the desired protein product. Preferred products of expression lack bio-inactivating leader sequences common in eukaryotic expression products but problematic with regard to microbial cleavage to yield bioactive material. Illustrative is a preferred embodiment in which a gene coding for human growth hormone (useful in, e.g., treatment of hypopituitary dwarfism) is constructed and expressed.|
|Inventor(s):||Goeddel; David V. (Burlingame, CA), Heyneker; Herbert L. (Burlingame, CA)|
|Assignee:||Genentech, Inc. (South San Francisco, CA)|
|Filing Date:||Apr 13, 1987|
|Claims:||1. A DNA molecule consisting of DNA encoding amino acids 1-191 of human growth hormone. |
2. A DNA molecule consisting of DNA encoding methionine joined to the 5'-terminus of DNA encoding amino acids 1-191 of human growth hormone.
3. A DNA molecule comprising DNA encoding amino acids 1-191 of human growth hormone joined to DNA encoding an amino acid sequence that is specifically cleavable so as to permit extracellular cleavage of human growth hormone, unaccompanied by its leader sequence or other extraneous protein, from a proteolysis-resistant conjugate after expression of said conjugate.
4. A DNA molecule comprising the DNA molecule of claim 3 inserted into a replicable cloning vehicle.
5. The DNA molecule of claim 4 wherein the replicable cloning vehicle is a bacterial plasmid.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.